Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pileri

Showing results (921-930 of 992) with videos related to

Pageof 100
Sort By:
Hematological Oncology|September 9, 2022
Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma projectCarlos Chiattone, Monica Civallero, Thais Fischer, et al.
Haematologica|August 21, 2020
A three-gene signature based on <i>MYC</i>, <i>BCL-2</i> and <i>NFKBIA</i> improves risk stratification in diffuse large B-cell lymphomaEnrico Derenzini, Saveria Mazzara, Federica Melle, et al.
Blood|December 4, 2004
Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca(2+)-dependent association with annexin VIEnrico Tiacci, Pier-Luigi Orvietani, Barbara Bigerna, et al.
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
T-cell lymphomas in South america and europeMonica Bellei, Carlos Sergio Chiattone, Stefano Luminari, et al.
Journal of Hematology & Oncology|November 7, 2015
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemiaIlaria Iacobucci, Andrea Ghelli Luserna Di Rorà, Maria Vittoria Verga Falzacappa, et al.
Cell Reports|April 20, 2022
Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphomaJose R Cortes, Ioan Filip, Robert Albero, et al.
Cancer|May 27, 2003
High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrenceCorrado Tarella, Alessandra Cuttica, Umberto Vitolo, et al.
Blood Cancer Journal|November 11, 2014
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specifiedM A Laginestra, P P Piccaluga, F Fuligni, et al.
Iscience|April 25, 2025
Downregulation of rRNA synthesis by BCL-2 induces chemoresistance in diffuse large B cell lymphomaAlessandra Rossi, Saveria Mazzara, Dorotea Salemi, et al.
The Lancet. Haematology|December 9, 2016
Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana LinfomiCarlo Visco, Annalisa Chiappella, Luca Nassi, et al.
Pageof 100

Showing results (921-930 of 992) with videos related to

Sort By:
Pageof 100
Hematological Oncology|September 9, 2022
Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma projectCarlos Chiattone, Monica Civallero, Thais Fischer, et al.
Haematologica|August 21, 2020
A three-gene signature based on <i>MYC</i>, <i>BCL-2</i> and <i>NFKBIA</i> improves risk stratification in diffuse large B-cell lymphomaEnrico Derenzini, Saveria Mazzara, Federica Melle, et al.
Blood|December 4, 2004
Tumor protein D52 (TPD52): a novel B-cell/plasma-cell molecule with unique expression pattern and Ca(2+)-dependent association with annexin VIEnrico Tiacci, Pier-Luigi Orvietani, Barbara Bigerna, et al.
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
T-cell lymphomas in South america and europeMonica Bellei, Carlos Sergio Chiattone, Stefano Luminari, et al.
Journal of Hematology & Oncology|November 7, 2015
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemiaIlaria Iacobucci, Andrea Ghelli Luserna Di Rorà, Maria Vittoria Verga Falzacappa, et al.
Cell Reports|April 20, 2022
Oncogenic Vav1-Myo1f induces therapeutically targetable macrophage-rich tumor microenvironment in peripheral T cell lymphomaJose R Cortes, Ioan Filip, Robert Albero, et al.
Cancer|May 27, 2003
High-dose sequential chemotherapy and peripheral blood progenitor cell autografting in patients with refractory and/or recurrent Hodgkin lymphoma: a multicenter study of the intergruppo Italiano Linfomi showing prolonged disease free survival in patients treated at first recurrenceCorrado Tarella, Alessandra Cuttica, Umberto Vitolo, et al.
Blood Cancer Journal|November 11, 2014
Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specifiedM A Laginestra, P P Piccaluga, F Fuligni, et al.
Iscience|April 25, 2025
Downregulation of rRNA synthesis by BCL-2 induces chemoresistance in diffuse large B cell lymphomaAlessandra Rossi, Saveria Mazzara, Dorotea Salemi, et al.
The Lancet. Haematology|December 9, 2016
Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana LinfomiCarlo Visco, Annalisa Chiappella, Luca Nassi, et al.
Pageof 100